The present review summarizes how the retrograde BDNF/TrkB signaling pathway and the downstream alteration of protein kinases C is disturbed from its physiological mechanism in ALS at the NMJ and how exercise and other therapies that modulate kinases are effective at delaying ALS’s progression. The gene discussed is NTRK2; the disease is amyotrophic lateral sclerosis.